VRAX Virax Biolabs Group Limited: Accounting Value per Share

Graphic logo of Virax Biolabs Group Limited (VRAX)

Following the pandemic, Virax Biolabs Group (VRAX) faced an oversupply and a forced sell-off of inventories. The calculated book value per share on this chart illustrates capital dynamics, where 13.07 determines the current status of the parameter. Meanwhile, the business relies on AI-driven immunity analysis for precise diagnostics and is implementing mobile early detection systems for global biological threats.

Virax Biolabs Group Limited (VRAX) - Accounting Value per Share from 04/28/2023 to 10/28/2026

Summary analytical data breakdowns for viraxbiolabs.com (VRAX)

- price and consensus price forecast:
Stock Price Virax Biolabs Group Ltd|VRAX - Analyst Consensus Forecast
- market capitalization data:
Market Valuation Virax Biolabs Group|VRAX - Business Value
- book capitalization data:
Net Assets per Single Share Virax Biolabs|VRAX - Company Net Assets|Market Capitalization to Book Value Ratio viraxbiolabs.com|VRAX - Company Assets
- debt and liquidity data:
Total Debt to Capital Virax Biolabs Group|VRAX - Long-Term Debt to Capital Ratio|Short-Term Debt to Capital Virax Biolabs|VRAX - Company Aggregate Debts|Debt to Book Capitalization Ratio Virax Biolabs Group|VRAX - Company Long-Term Indebtedness|Company Short-Term Debts Virax Biolabs
Fundamental company valuation:Virax Biolabs Group
Manufactured product of viraxbiolabs.com

Virax Biolabs Group's expansion into the mobile diagnostic platforms segment drives net asset value growth by expanding its material base. This metric reflects the liquidation value per share, calculated as the difference between all assets and liabilities, which allows the book value per common share to assess the business's real foundation and capital accumulation efficiency without market noise.

Competitors of Virax Biolabs Group (VRAX)

Agilent Tech - Book Value per Share|Quest Corp (DGX) - Book Value per Share|Accounting Value per Share Illumina, Inc.|EXAS (exactsciences.com) - Equity per Share|Net Assets per Single Share RVTY|Accounting Value per Share Bio-Rad Laboratories, Inc.|Anbio Tech - Book Value per Share|Net Asset Value per Share Nordion (SHC)|QDEL - Book Value per Share|Equity per Share opko.com OPK|CareDx, Inc - Book Value per Share|MRVI: Book Value per Share|Net Assets per Single Share Fulgent Corp|Standard BioTools Corp (LAB) - Equity per Share|CTKB (Cytek Biosciences, Inc.) - Book Value per Share|Book Value per Share OSUR|Net Assets per Single Share Exagen Inc. (XGN)|Net Assets per Single Share MDxHealth S.A. MDXH|LUCD: Accounting Value per Share|Prenetics Global Limited - Net Asset Value per Share|Net Assets per Single Share IMDX (Insight Molecular)|TRIB - Net Assets per Share|ProPhase Labs - Book Value per Share|AIMD (Ainos Inc) - Net Assets per Share|CODX: Net Assets per Single Share|Net Assets per Share Heart Test Labs (HSCS)|Accounting Value per Share Biomerica, Inc. (BMRA)|Net Assets per Single Share cardiodiagnosticsinc.com (CDIO)|Book Value per Share BJDX|Aspira Women's Health, Inc. - Net Assets per Share|Net Assets per Single Share Accelerate Diagnostics, Inc (AXDX)|CNTG - Accounting Value of a Share|ENZ: Book Value per Share|Book Value per Share Fresh2 Group|Accounting Value per Share Genetic Technologies Ltd (GENE)|Equity per Share 23andMe Holding Co (ME)|Psychemedics Corp (PMD) - Accounting Value per Share